19 - 22 Oct 2025 | Las Vegas

Women Aren't Just Small Men

About this Session:

For decades, women's health research in pharma operated under the mind-boggling assumption that female biology was basically male biology with some inconvenient monthly variations, a scientific blind spot that left half the population taking medications tested primarily on men and dealing with conditions that were either ignored or misunderstood. But companies are finally waking up to the fact that women represent not just an underserved market, but a massive untapped opportunity worth hundreds of billions of dollars. From periods and pregnancy to chronic disease, pharma is investing in areas that were once considered "niche," discovering that conditions like endometriosis, PCOS, and menopause affect hundreds of millions of women who've been desperately seeking effective treatments for generations. The shift isn't just about doing the right thing, it's about recognizing that women control 80% of healthcare decisions and are increasingly willing to invest in solutions that actually understand their unique biology, creating a market opportunity that's both massive and barely scratched.